Will Savage

Will Savage currently serves as the Chief Medical Officer, bringing a robust background in medical research and clinical practice, particularly in pediatric hematology/oncology and transfusion medicine. He began his career at Johns Hopkins University School of Medicine, where he trained in pediatric hematology/oncology and transfusion medicine. Savage received a BA in Biochemistry magna cum laude from Columbia University, followed by an MD with honors in research from Weill Cornell Medical College. He further enhanced his expertise with a PhD in Clinical Investigation from the Johns Hopkins Bloomberg School of Public Health. Prior to his current role, he was a Senior Medical Director at Magenta Therapeutics and the Global Clinical Development Lead in Hematology at Shire/Takeda. Additionally, he served as an Assistant Professor of Pathology at Harvard Medical School and Brigham and Women’s Hospital, contributing significantly to medical education and research.